October 2022
Pandemic Response Lab Launches Novel Triple-target Monkeypox Tests
Increased capacity, accuracy and accelerated turnaround time now makes monkeypox testing available at scale to curb the virus spread.
Long Island City, N.Y., Oct. 13, 2022 — Pandemic Response Lab (PRL), a wholly owned subsidiary of Opentrons Labworks, Inc., today announced two new three-target monkeypox tests, each developed and performed by its New York and Maryland laboratories, respectively. These skin lesion tests qualitatively detect three different viral genome targets of increasing spe